Navigation Links
New Journal to Explore Neurodegenerative, Neuroprotective and Euroregenerative Therapies!

WESTON, Mass., Oct. 2 /PRNewswire/ -- Weston Medical Publishing today announced publication of the first issue of Journal of Neurodegeneration and Regeneration. (ISSN 1932-1481) This new peer-reviewed journal is designed to explore all aspects of neurodegeneration, neuroprotection and neuroregeneration including the molecular mechanisms, experimental approaches and their relevance in treating neurodegenerative disorders and neuroregenerative therapies.

When making the announcement, Publisher, Richard A. DeVito Jr. pointed out that while diagnosis may be the first step on the road of long term care for neurodegenerative patients, the pot of gold at the end of this difficult road will come from the challenging new frontier of neuroprotection and neuroregeneration research.

With the introduction of Journal of Neurodegeneration and Regeneration, (available online free of charge at until October 15th, 2008), the top neurospecialists worldwide will meet this challenge and bring to the medical community a long awaited exploration of the on-going research being conducted in this critical field.

Said DeVito, "The element of urgency couldn't be clearer. The numbers speak for themselves. In the United States alone, almost five million suffer from Alzheimer's disease; one million from Parkinson's disease; 400,000 from multiple sclerosis; and 30,000 from ALS. Worldwide, these four diseases account for more than 20 million patients."

"Further," he went on to say, "It is generally accepted that things are going to get worse before they get better. Aging greatly increases the risk of neurodegenerative disease and the average age of Americans and the worldwide populations are increasing. Today, over 37 million Americans alone are over the age of 65. Within the next 30 years this number is likely to double, putting more and more people at increased risk of neurodegenerative diseases."

"Research," DeVito noted, "will lead to better diagnosis, more effective treatments and, perhaps, cures for diseases like Alzheimer's, Parkinson's, multiple sclerosis, ALS and other diseases where few effective treatments and no cures are currently available."

The Journal of Neurodegeneration and Regeneration is guided by an international editorial review board of the foremost experts in the field under the leadership of co-Editors-in-Chief Dr. Philippe Taupin, PhD and Dr. Cathy Helgason, MD.

For manuscript submission or subscription information, visit the journal's Web page at or contact the publisher, Weston Medical Publishing LLC, at 781-899-2702.

Contact: Richard A. DeVito, Jr.

Weston Medical Publishing


SOURCE Weston Medical Publishing
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. News briefs from the journal Chest, August 2007
2. The New England Journal of Medicine Publishes EURIDIS/ADONIS Study Results Showing Dronedarone Maintained Sinus Rhythm in Patients With Atrial Fibrillation or Flutter With no Observed Pro-Arrhythmia
3. Elsevier launches new journal: Stem Cell Research
4. Elsevier announces new journal on inflammatory bowel diseases
5. National Osteoporosis Foundation Teams Up With Ladies Home Journal Magazine to Launch a 10-city Mall Walk Tour
6. Cleveland Clinic Press Releases Journal-Writing Book Write for Life: Healing Body, Mind, and Spirit Through Journal Writing by Sheppard B. Kominars, Ph.D.
7. Good Clinical Practice Journal Awards: Winners Announced
8. Maimonides Expands Circulation of Physicians Practice Journal to Staten Island Doctors
9. American Heart Association Surgical Supplement Journal Report: Appropriate Hospital Discharge System Can Prevent Future Cardiac Events
10. Takeda statement on ACTOS meta-analysis published in the Journal of the American Medical Association
11. Takeda Statement on ACTOS(R) (Pioglitazone HCl) Meta-Analysis Published in the Journal of the American Medical Association
Post Your Comments:
(Date:10/13/2015)... ... ... Scientists in Seattle and Vancouver compared the diagnostic value of lung fluid cytology ... has just posted an article on the new research. Click here to read ... of British Columbia found that certain genetic alterations were seen just as often in ...
(Date:10/13/2015)... ... October 13, 2015 , ... Tempe Dental Care, a leading Tempe ... and IV sedation dentistry for more than 5 years. A leading cause ... serious and painful if treatment is not timely. , Sedation dentistry ...
(Date:10/13/2015)... (PRWEB) , ... October 13, 2015 , ... Local Gold’s ... Gold’s Gym International Conference on August 26. Berry, who owns and operates Gold's ... for the fastest growing Gold’s Gyms in the United States. A brand leader in ...
(Date:10/13/2015)... ... October 13, 2015 , ... Thermi, an ... newest professional to introduce the latest development, ThermiVa® temperature controlled radiofrequency to the ... professional in Obstetrics and Gynecology and a pioneer in the field of laparoscopy. ...
(Date:10/13/2015)... ... October 13, 2015 , ... In an ongoing effort ... , a Southlake, Texas, child development and pediatric therapy center, is working with ... families about their options for receiving this kind of care for affected children. ...
Breaking Medicine News(10 mins):
(Date:10/13/2015)... Calif. , Oct. 13, 2015  SRI ... up to $100 million over five years by ... (NIAID), part of the National Institutes of Health, ... treat acute or delayed effects of radiation exposure. ... a division of SRI International will provide services, ...
(Date:10/13/2015)... , Oct. 13 2015 ... the addition of the "US & ... 16 Countries (2010-2021)" report to their ... announced the addition of the "US ... - 16 Countries (2010-2021)" report to ...
(Date:10/13/2015)... 13, 2015 anesthesia and respiratory ... billion by 2022, according to a new report by ... to their capability to resolve various environmental and lifestyle ... growth. --> anesthesia and respiratory devices market ... 2022, according to a new report by Grand View ...
Breaking Medicine Technology: